DRIVIN G ROWTH - Dr. Reddy's

notes to the financial statements – DECEMBER 31, 2001
5. OTHER RECEIVABLES & DEPOSITS
REDDY PHARMACEUTICALS SINGAPORE PTE LTD. | FINANCIALS | ANNUAL REPORT 2001
S$
2001 2000
Related Company (Note 3) 199,637 163,462
Deposits 9,114 9,314
6. AMOUNT DUE FROM A DIRECTOR
The amounts due are unsecured, interest free and with no fixed terms of repayment.
7. TRADE PAYABLES
208,751 172,776
Outside parties 1,524,090 1,870,054
Ultimate holding Company (Note 3) 765,971 996,646
2,290,061 2,866,700
8. REVENUE
Revenue represents invoiced value of goods sold.
9. OTHER OPERATING INCOME
Interest on bank balances 1,450 2,116
Foreign currency exchange adjustment gain – 180,823
Management fee 140,000 140,000
Miscellaneous 4,115 –
10.(LOSS)/PROFIT BEFORE INCOME TAX
145,565 322,939
In addition to the changes and credits disclosed elsewhere in the
notes to the Profit and Loss Statements, this item includes the
following changes (credits):
Auditors’ remuneration 3,000 3,000
Depreciation of fixed assets
Directors’ emoluments:
3,751 5,382
– Directors’ accommodation 10,000 24,600
– Directors’ fee – 66,000
Amortisation of pre-incorporation expenses 1,227 306
Foreign currency exchange adjustment loss 48,553 –
11.INCOME TAX
The Company has tax loss carry forward available for offsetting
against future taxable income as follows:
Amount at beginning of financial year 512,848 619,400
Amount utilised in current financial year (36,963) (106,552)
Amount at end of financial year 475,885 512,848
Deferred tax benefit on above unrecorded 116,592 130,776
The realisation of the future income tax benefits from tax loss carry forwards is available for an unlimited future period subject to
the conditions imposed by law including the retention of majority shareholders as defined.
12.CASH AND CASH EQUIVALENTS
These comprises of cash on hand and bank balances.
239